A pilot phase II study of pre-operative radiation therapy and thalidomide (IND 48832; NSC 66847) for low grade primary soft tissue sarcoma or pre-operative MAID [doxorubicin, ifosfamide, dacarbazine]/thalidomide/radiation therapy for high/intermediate-grade primary soft tissue sarcoma of the extremity or body wall

Trial Profile

A pilot phase II study of pre-operative radiation therapy and thalidomide (IND 48832; NSC 66847) for low grade primary soft tissue sarcoma or pre-operative MAID [doxorubicin, ifosfamide, dacarbazine]/thalidomide/radiation therapy for high/intermediate-grade primary soft tissue sarcoma of the extremity or body wall

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2013

At a glance

  • Drugs Thalidomide (Primary) ; Dacarbazine; Doxorubicin; Ifosfamide
  • Indications Sarcoma; Soft tissue sarcoma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 31 May 2012 Inclusion and exclusion criteria amended as reported by ClinicalTrials.gov.
    • 31 May 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 31 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top